LOS ANGELES, CA–(Marketwired – Aug 18, 2015) – GAWK Inc. (OTC PINK: GAWK), through its wholly owned subsidiary, WebRunners, Inc., announced today a signature client win with the signing of an agreement with BioAdaptives, Inc. (OTCBB: BDPT), in conjunction with the Company rolling out its first five products nationwide.
Scott Kettle, CEO of GAWK, Inc., said, “We are most pleased that BioAdaptives chose GAWK for its new Cloud and global CDN platform. We will assist the Company with website design, online presence, and with support of their online stores.
Our new suite of Cloud products with full product integration allows our customers to sign up, provision and manage their cloud servers from a single location.”
Barry Epling, Chairman of BioAdaptives, noted, “GAWK and WebRunners provides our Company with state-of-the-art data management. We are confident that GAWK’s cloud platform and guidance with the development of our planned new site, scheduled to be launched September 1, 2015, provides BioAdaptives maximum visibility, while we concentrate on producing natural, high quality, cutting edge nutraceutical blends for humans, pets and the equine markets.
All statements in this release that are not strictly historical facts are “forward-looking statements.” Such forward-looking statements are based on GAWK’s current assumptions, beliefs and expectations, and involve risks, uncertainties and other factors that may cause GAWK’s actual results to be materially different from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words such as “expect,” “plan,” “possibility,” “offer,” “if,” “negotiate,” “when,” “believe,” “will,” “estimate,” “continue,” and similar expressions. Risks, uncertainties, and other factors that could cause or contribute to such differences include, but are not limited to: ongoing and future intellectual property enforcement actions; the ability to successfully litigate or settle claims of patent infringement; GAWK’s ability to obtain necessary financing, generate sufficient cash flow, and maintain appropriate indebtedness; and the increasing development of market competition in the area of telecommunications. These factors and others are described in more detail in GAWK’s public filings with the Securities and Exchange Commission, including the risks discussed in the “Risk Factors” section in GAWK’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Copies of these reports can be found on GAWK’s website (http://gawkinc.com) under the heading “Investor Relations.” GAWK is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-looking statements contained herein as a result of new information, future events or otherwise.
About GAWK, Inc.
Gawk Incorporated is a world innovator of digital Internet-related technology designed to meet the needs of modern consumers, businesses and enterprises globally. www.gawkinc.com
About BioAdaptives, Inc.
BioAdaptives, Inc. is a fully reporting, public company trading on the OTC Bulletin Board under the symbol BDPT. The company is engaged in research and development in science-based nutraceutical products for human and animal consumption. The company’s focus is to source high quality, unique, raw material worldwide and develops science-based products to improve health and wellness in both humans and animals. BioAdaptives, Inc. owns the rights to a proprietary method that is a non-invasive bioelectromagnetic device for improving individual ingredients, food, beverages, and wellness.